Redmile Group reported a 9.9% stake in Atara Biotherapeutics ATRA · 950,994 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 9.9%
Last report: 9.9% · filed 25/11/14
Shares held: 950,994 sh
Class: Common Stock, par value $0.0001 per share
Stock: Atara Biotherapeutics ATRA
Holder: Redmile Group
Event date: 26/05/12
Filed: 26/05/14

9.9% stake · +0.0pp from the last report

Stake: 9.9%
Last report: 9.9%
Since last report: +0.0pp

Atara Biotherapeutics trades, last 26 weeks

What else happened in Atara Biotherapeutics around then

Filed or reported within 30 days of the trade day · 04/12~06/11

Redmile Group's other 5% stake reports

Redmile Group
5% stakeElectra Therapeutics
5% stake
Electra Therapeutics
ETRA
8.7% stake
5,462,881 sh
8.7% stake
Filed 09/28
Redmile Group
5% stakeNurix Therapeutics
5% stake
Nurix Therapeutics
NRIX
8.1% stake
8,782,256 sh
8.1% stake
Filed 08/14
Redmile Group
5% stakeScholar Rock Holding
5% stake
Scholar Rock Holding
SRRK
3.6% stake
4,311,092 sh
3.6% stake
Filed 08/14
Redmile Group
5% stakeAtara Biotherapeutics
5% stake
Atara Biotherapeutics
ATRA
9.9% stake
950,994 sh
9.9% stake
Filed 07/24
Redmile Group
5% stakeShattuck Labs
5% stake
Shattuck Labs
STTK
9.9% stake
10,019,421 sh
9.9% stake
Filed 07/17